Tradeweb Markets enters the back half of August with a quiet but notable divergence: short sellers are walking back positions at a double-digit weekly pace, while the analysts who cover the stock are still digesting an earnings quarter that left most of them reaching for red pens.
The clearest story in the positioning data is the short exit. Short interest dropped more than 10% in one week to 3.2% of the free float — equivalent to roughly 3.8 million shares — the sharpest weekly decline in at least six weeks. Earlier in August, shorts had built positions toward 4.3 million shares; that whole move has now been unwound. The borrow market reflects the easing demand: cost to borrow has fallen nearly 15% on the week to a low 0.38%, and availability is effectively unlimited at over 9,000% of outstanding short interest. There is no squeeze pressure here, and no premium on the borrow. Options are mildly more cautious than their recent baseline — the put/call ratio is running at 0.27, about one standard deviation above its 20-day average of 0.21 — but still sits in the lower half of its 52-week range, nowhere near the defensive extreme of 1.39 seen earlier in the year. Overall, positioning looks more relaxed than worried.
The Street picture is less settled. The company's Q2 earnings in late July triggered a wave of target cuts: JP Morgan, TD Cowen, Piper Sandler, and Barclays all trimmed price targets after the print, with JP Morgan's Kenneth Worthington — who filed a second cut on August 3, bringing his target from $125 to $117 — twice revising lower in the space of a month. None of those firms changed their ratings, which points to a "still positive, but less so" posture rather than an outright re-evaluation. The mean analyst target now sits at roughly $124, implying about 17% upside from the current $105.47 close, though that figure is dragged higher by Raymond James's outlier $151 target and Goldman Sachs's $146 following its late-June upgrade to Buy. The valuation has re-rated modestly: the PE multiple has climbed around 5% in the past 30 days to about 24x, tracking the 5.6% monthly price gain. Factor scores are middling across the board — EPS momentum in the low 40s percentile, EPS 12-month forward growth ranking a weak 13th percentile — suggesting the Street's relative caution is well-founded in the fundamental data.
One institutional footnote worth noting: Carmignac Gestion added roughly 1.6 million shares as of June 30, making it one of the more active buyers among the named holders over that period. London Stock Exchange Group, the dominant holder at nearly 46% of shares, has not moved its position. Insider flow is entirely sell-side — a mix of CTO, CFO, Managing Director, and director disposals over recent months — though all are small relative to the company's float and carry low significance scores.
The earnings print on October 29 will be the next hard test. The July 30 quarter produced a single-day drop of 7.1% and a five-day loss of 4.5% — the largest near-term reaction in the available history. Peers have generally had a stronger week: CME gained 4.7% and ICE added 3.3%, while Tradeweb managed just 1.0%. LSEG was the laggard, sliding 3.4%. Whether Tradeweb can close that relative gap before October — and whether the analyst community stabilises its price targets — are the metrics worth tracking into Q3.
See the live data behind this article on ORTEX.
Open TW on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
